NO20081230L - Inhibitorer av enzymet HIV integrase - Google Patents

Inhibitorer av enzymet HIV integrase

Info

Publication number: NO20081230L
Authority: NO; Norway
Prior art keywords: inhibitors; hiv integrase; enzyme hiv; enzyme; integrase
Prior art date: 2005-10-07

Application number

NO20081230A

Other languages

English (en)

Norwegian (no)

Inventor

Klaus Ruprecht Dress

Ted William Johnson

Michael Bruno Plewe

Steven Paul Tanis

Huichun Zhu

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-07

Filing date

2008-03-07

Publication date

2008-04-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081230(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-07 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2008-04-08 Publication of NO20081230L publication Critical patent/NO20081230L/no

Links

239000003112 inhibitor Substances 0.000 title abstract 2
108010002459 HIV Integrase Proteins 0.000 title 1
241000725303 Human immunodeficiency virus Species 0.000 abstract 2
102000004190 Enzymes Human genes 0.000 abstract 1
108090000790 Enzymes Proteins 0.000 abstract 1
102100034343 Integrase Human genes 0.000 abstract 1
108010061833 Integrases Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Tropical Medicine & Parasitology (AREA)
General Chemical & Material Sciences (AREA)
AIDS & HIV (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20081230A 2005-10-07 2008-03-07 Inhibitorer av enzymet HIV integrase NO20081230L (no)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US72448405P	2005-10-07	2005-10-07
US73070105P	2005-10-26	2005-10-26
US76160506P	2006-01-24	2006-01-24
US82395406P	2006-08-30	2006-08-30
US82637906P	2006-09-20	2006-09-20
PCT/IB2006/002735 WO2007042883A1 (en)	2005-10-07	2006-09-25	Inhibitors of the hiv integrase enzyme

Publications (1)

Publication Number	Publication Date
NO20081230L true NO20081230L (no)	2008-04-08

Family

ID=37684843

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081230A NO20081230L (no)	2005-10-07	2008-03-07	Inhibitorer av enzymet HIV integrase

Country Status (21)

Country	Link
US (1)	US20070099915A1 (sr)
EP (1)	EP1934220A1 (sr)
JP (1)	JP2009511463A (sr)
KR (1)	KR20080042171A (sr)
AP (1)	AP2008004400A0 (sr)
AR (1)	AR061398A1 (sr)
AU (1)	AU2006300926A1 (sr)
BR (1)	BRPI0616657A2 (sr)
CA (1)	CA2623506A1 (sr)
CR (1)	CR9859A (sr)
EA (1)	EA200800758A1 (sr)
IL (1)	IL189939A0 (sr)
MA (1)	MA29855B1 (sr)
NL (1)	NL2000255A1 (sr)
NO (1)	NO20081230L (sr)
PE (1)	PE20070494A1 (sr)
RS (1)	RS20080141A (sr)
SV (1)	SV2009002864A (sr)
TW (1)	TW200800219A (sr)
UY (1)	UY29843A1 (sr)
WO (1)	WO2007042883A1 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005103051A1 (en) *	2004-04-26	2005-11-03	Pfizer Inc.	Inhibitors of the hiv integrase enzyme
JP2011517313A (ja)	2007-12-11	2011-06-02	ビアメトファーマシューティカルズ，インク．	金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
CN102532021B (zh) *	2012-01-31	2013-10-16	天津大学	2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ194747A (en) *	1979-08-29	1988-11-29	Schering Ag	9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
US5616609A (en) *	1991-08-08	1997-04-01	Ikekawa; Tetsuro	Carcinostatic compound and production thereof
EP0713877A1 (en) *	1993-07-19	1996-05-29	LUO, Xuande	Qinghaosu derivatives against aids
US6057297A (en) *	1996-08-06	2000-05-02	Polifarma S.P.A.	Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) *	1996-10-08	1998-10-30	Synthelabo	Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) *	1998-02-03	2002-06-11	Merck & Co., Inc.	HIV integrase inhibitors
AU8009900A (en) *	1999-10-13	2001-04-23	Merck & Co., Inc.	Hiv integrase inhibitors
AU2001269895B2 (en) *	2000-06-16	2005-10-20	Bristol-Myers Squibb Company	Hiv integrase inhibitors
PA8586801A1 (es) *	2002-10-31	2005-02-04	Pfizer	Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
WO2004067531A1 (en) *	2003-01-27	2004-08-12	Pfizer Inc.	Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
WO2005103051A1 (en) *	2004-04-26	2005-11-03	Pfizer Inc.	Inhibitors of the hiv integrase enzyme
US20070232644A1 (en) *	2004-09-07	2007-10-04	Pfizer Inc.	Inhibitors of the Hiv Integrase Enzyme

2006
- 2006-09-25 JP JP2008534098A patent/JP2009511463A/ja not_active Withdrawn
- 2006-09-25 BR BRPI0616657-1A patent/BRPI0616657A2/pt not_active Application Discontinuation
- 2006-09-25 EP EP06808923A patent/EP1934220A1/en not_active Withdrawn
- 2006-09-25 EA EA200800758A patent/EA200800758A1/ru unknown
- 2006-09-25 CA CA002623506A patent/CA2623506A1/en not_active Abandoned
- 2006-09-25 AP AP2008004400A patent/AP2008004400A0/xx unknown
- 2006-09-25 WO PCT/IB2006/002735 patent/WO2007042883A1/en not_active Ceased
- 2006-09-25 AU AU2006300926A patent/AU2006300926A1/en not_active Abandoned
- 2006-09-25 RS RSP-2008/0141A patent/RS20080141A/sr unknown
- 2006-09-25 KR KR1020087008162A patent/KR20080042171A/ko not_active Ceased
- 2006-10-03 NL NL2000255A patent/NL2000255A1/nl active Search and Examination
- 2006-10-04 AR ARP060104374A patent/AR061398A1/es not_active Application Discontinuation
- 2006-10-05 PE PE2006001216A patent/PE20070494A1/es not_active Application Discontinuation
- 2006-10-05 TW TW095137139A patent/TW200800219A/zh unknown
- 2006-10-06 UY UY29843A patent/UY29843A1/es not_active Application Discontinuation
- 2006-10-06 US US11/539,205 patent/US20070099915A1/en not_active Abandoned
2008
- 2008-02-04 CR CR9859A patent/CR9859A/es not_active Application Discontinuation
- 2008-03-04 IL IL189939A patent/IL189939A0/en unknown
- 2008-03-07 NO NO20081230A patent/NO20081230L/no not_active Application Discontinuation
- 2008-04-07 MA MA30821A patent/MA29855B1/fr unknown
- 2008-04-07 SV SV2008002864A patent/SV2009002864A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2009511463A (ja)	2009-03-19
KR20080042171A (ko)	2008-05-14
UY29843A1 (es)	2007-05-31
PE20070494A1 (es)	2007-06-13
MA29855B1 (fr)	2008-10-03
CR9859A (es)	2008-06-20
BRPI0616657A2 (pt)	2011-06-28
AP2008004400A0 (en)	2008-04-30
IL189939A0 (en)	2008-08-07
AR061398A1 (es)	2008-08-27
EA200800758A1 (ru)	2008-08-29
SV2009002864A (es)	2009-02-19
EP1934220A1 (en)	2008-06-25
TW200800219A (en)	2008-01-01
NL2000255A1 (nl)	2007-04-11
RS20080141A (sr)	2009-07-15
AU2006300926A1 (en)	2007-04-19
US20070099915A1 (en)	2007-05-03
WO2007042883A1 (en)	2007-04-19
CA2623506A1 (en)	2007-04-19

Legal Events

Date	Code	Title	Description
2010-04-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
WO2005115398A3 (en)	2006-04-20	Hiv integrase inhibitors
NO20081844L (no)	2008-05-29	Terapeutiske forbindelser
NO20063925L (no)	2006-09-01	Indazolderivater som inhibitorer av hormonsensitiv lipase
NO20055135L (no)	2005-12-14	Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
WO2009146555A8 (en)	2010-12-23	Hiv integrase inhibitors from pyridoxine
NO20081878L (no)	2008-04-18	Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
NO20044534L (no)	2004-12-22	Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
NO20066055L (no)	2007-01-24	Pyridinderivater
NO20091299L (no)	2009-04-29	Substituerte sulfonamidderivater
NO20070751L (no)	2007-05-07	Inhibitorer av HCV-replifikasjon
NO20063958L (no)	2006-09-22	HIV integrase inhibitorer
NO20073404L (no)	2007-07-02	Kaliumsalt av en HIV-integraseinhibitor
NO20075992L (no)	2008-02-13	Forbindelser som modulerer C-Kit og C-FMS aktivitet og anvendelser derav
TN2010000212A1 (en)	2011-11-11	Inhibitors of human immunodeficiency virus replication
NO20021328L (no)	2002-05-21	Pyrazolopyrimidier som terapeutiske midler
WO2008118849A3 (en)	2008-12-18	Hiv-1 protease inhibitors
NO20081942L (no)	2008-04-23	Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
DK1569929T3 (da)	2010-08-16	Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
NO20084049L (no)	2008-10-20	Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
WO2007013047A3 (en)	2007-05-31	Water-dispersible anti-retroviral pharmaceutical compositions
NO20076145L (no)	2008-01-28	Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20082130L (no)	2008-06-23	3-Amino-1-arylpropylindoler og aza-substituerte indoler
NO20062021L (no)	2006-07-07	Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
NL1024676A1 (nl)	2004-05-06	HIV integrase-remmers, farmaceutische preparaten en methoden voor het gebruik daarvan.
NO20050666L (no)	2005-03-11	2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer